Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada
- 1 July 1998
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 31 (3), 437-451
- https://doi.org/10.1016/s0732-8893(98)80002-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1997
- Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USADiagnostic Microbiology and Infectious Disease, 1997
- Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests.Journal of Antimicrobial Chemotherapy, 1997
- The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humansJournal of Antimicrobial Chemotherapy, 1997
- Emergence of Increased Resistance to Quinupristin/ Dalfopristin During Therapy for Enterococcus faecium BacteremiaClinical Infectious Diseases, 1997
- Comparative in-vitro activity of quinupristin/ dalfopristin (RP 59500) tested against penlcillin-and macrolide-resistant pneumococci by the EtestJournal of Antimicrobial Chemotherapy, 1996
- Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faeciumDiagnostic Microbiology and Infectious Disease, 1996
- Mechanisms of glycopeptide resistance in enterococciJournal of Infection, 1996
- RP 59500, a new streptogramin highly active against recent isolates of North American staphylococciDiagnostic Microbiology and Infectious Disease, 1993
- In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993